239 related articles for article (PubMed ID: 2752978)
21. Effects of estrogen and parathyroid hormone on osteoblastic activity via regulating the binding activity of insulin-like growth factor binding protein-4 in SaOS-2 cells: implications for the pathogenesis of postmenopausal osteoporosis.
Kudo Y; Itatsu S; Iwashita M; Iguchi T; Takeda Y
Biochim Biophys Acta; 1995 Dec; 1245(3):402-6. PubMed ID: 8541319
[TBL] [Abstract][Full Text] [Related]
22. Regulation of insulin-like growth factor-binding protein-4 protease activity by estrogen and parathyroid hormone in SaOS-2 cells: implications for the pathogenesis of postmenopausal osteoporosis.
Kudo Y; Iwashita M; Itatsu S; Iguchi T; Takeda Y
J Endocrinol; 1996 Aug; 150(2):223-9. PubMed ID: 8869589
[TBL] [Abstract][Full Text] [Related]
23. Prostaglandin E2 stimulates insulin-like growth factor I synthesis in osteoblast-enriched cultures from fetal rat bone.
McCarthy TL; Centrella M; Raisz LG; Canalis E
Endocrinology; 1991 Jun; 128(6):2895-900. PubMed ID: 1645254
[TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor-beta modulates receptor binding of calciotropic hormones and G protein-mediated adenylate cyclase responses in osteoblast-like cells.
Schneider HG; Michelangeli VP; Frampton RJ; Grogan JL; Ikeda K; Martin TJ; Findlay DM
Endocrinology; 1992 Sep; 131(3):1383-9. PubMed ID: 1324161
[TBL] [Abstract][Full Text] [Related]
25. 3',5'-Cyclic adenosine monophosphate activation in osteoblastic cells: effects on parathyroid hormone-1 receptors and osteoblastic differentiation in vitro.
Koh AJ; Beecher CA; Rosol TJ; McCauley LK
Endocrinology; 1999 Jul; 140(7):3154-62. PubMed ID: 10385409
[TBL] [Abstract][Full Text] [Related]
26. Estrogen blocks parathyroid hormone (PTH)-stimulated osteoclast-like cell formation by selectively affecting PTH-responsive cyclic adenosine monophosphate pathway.
Kaji H; Sugimoto T; Kanatani M; Nasu M; Chihara K
Endocrinology; 1996 Jun; 137(6):2217-24. PubMed ID: 8641168
[TBL] [Abstract][Full Text] [Related]
27. Evidence for heterogeneity of the osteoblastic phenotype determined with clonal rat bone cells established from transforming growth factor-beta-induced cell colonies grown anchorage independently in semisolid medium.
Guenther HL; Hofstetter W; Stutzer A; Mühlbauer R; Fleisch H
Endocrinology; 1989 Oct; 125(4):2092-102. PubMed ID: 2676479
[TBL] [Abstract][Full Text] [Related]
28. Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone.
Bikle DD; Sakata T; Leary C; Elalieh H; Ginzinger D; Rosen CJ; Beamer W; Majumdar S; Halloran BP
J Bone Miner Res; 2002 Sep; 17(9):1570-8. PubMed ID: 12211426
[TBL] [Abstract][Full Text] [Related]
29. Endogenous prostaglandin E2 and insulin-like growth factor 1 can modulate the levels of parathyroid hormone receptor in human osteoarthritic osteoblasts.
Hilal G; Massicotte F; Martel-Pelletier J; Fernandes JC; Pelletier JP; Lajeunesse D
J Bone Miner Res; 2001 Apr; 16(4):713-21. PubMed ID: 11315999
[TBL] [Abstract][Full Text] [Related]
30. Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture.
Qu Q; Perälä-Heape M; Kapanen A; Dahllund J; Salo J; Väänänen HK; Härkönen P
Bone; 1998 Mar; 22(3):201-9. PubMed ID: 9514212
[TBL] [Abstract][Full Text] [Related]
31. Calvariae from fetal mice with a disrupted Igf1 gene have reduced rates of collagen synthesis but maintain responsiveness to glucocorticoids.
Woitge HW; Kream BE
J Bone Miner Res; 2000 Oct; 15(10):1956-64. PubMed ID: 11028448
[TBL] [Abstract][Full Text] [Related]
32. Estrogen effects on insulin-like growth factor gene expression in a human osteoblastic cell line with high levels of estrogen receptor.
Kassem M; Okazaki R; Harris SA; Spelsberg TC; Conover CA; Riggs BL
Calcif Tissue Int; 1998 Jan; 62(1):60-6. PubMed ID: 9405735
[TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor and interleukin 1 inhibit parathyroid hormone-responsive adenylate cyclase in clonal osteoblast-like cells by down-regulating parathyroid hormone receptors.
Katz MS; Gutierrez GE; Mundy GR; Hymer TK; Caulfield MP; McKee RL
J Cell Physiol; 1992 Oct; 153(1):206-13. PubMed ID: 1325978
[TBL] [Abstract][Full Text] [Related]
34. Thyroid hormone excess increases insulin-like growth factor I transcripts in bone marrow cell cultures: divergent effects on vertebral and femoral cell cultures.
Milne M; Kang MI; Quail JM; Baran DT
Endocrinology; 1998 May; 139(5):2527-34. PubMed ID: 9564868
[TBL] [Abstract][Full Text] [Related]
35. Skeletal unloading causes resistance of osteoprogenitor cells to parathyroid hormone and to insulin-like growth factor-I.
Kostenuik PJ; Harris J; Halloran BP; Turner RT; Morey-Holton ER; Bikle DD
J Bone Miner Res; 1999 Jan; 14(1):21-31. PubMed ID: 9893062
[TBL] [Abstract][Full Text] [Related]
36. Parathyroid hormone stimulates release of insulin-like growth factor-I (IGF-I) and IGF-II from neonatal mouse calvaria in organ culture.
Linkhart TA; Mohan S
Endocrinology; 1989 Sep; 125(3):1484-91. PubMed ID: 2759029
[TBL] [Abstract][Full Text] [Related]
37. 17 beta-estradiol and parathyroid hormone potentiate each other's stimulatory effects on alkaline phosphatase activity in SaOS-2 cells in a differentiation-dependent manner.
Rao LG; Wylie JN; Sutherland MS; Murray TM
Endocrinology; 1994 Feb; 134(2):614-20. PubMed ID: 8299560
[TBL] [Abstract][Full Text] [Related]
38. Transforming growth factor beta enhances parathyroid hormone stimulation of adenylate cyclase in clonal osteoblast-like cells.
Gutierrez GE; Mundy GR; Manning DR; Hewlett EL; Katz MS
J Cell Physiol; 1990 Sep; 144(3):438-47. PubMed ID: 2391378
[TBL] [Abstract][Full Text] [Related]
39. Effects of desamino-(1-3)-insulin-like growth factor I on bone cell function in rat calvarial cultures.
Canalis E; McCarthy TL; Centrella M
Endocrinology; 1991 Jul; 129(1):534-41. PubMed ID: 1647310
[TBL] [Abstract][Full Text] [Related]
40. Long-term culture in dexamethasone unmasks an abnormal phenotype in osteoblasts isolated from osteoporotic subjects.
Rao LG; Murray TM; Wylie JN; McBroom RJ; Sutherland MK
J Endocrinol Invest; 2005 Nov; 28(10):919-27. PubMed ID: 16419495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
